Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03219476
Title Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Letrozole

Tamoxifen

Exemestane

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.